Human Monoclonal Antibodies toPseudomonas aeruginosaAlginate That Protect against Infection by Both Mucoid and Nonmucoid Strains-Reference-Cited by-同舟云学术

Human Monoclonal Antibodies toPseudomonas aeruginosaAlginate That Protect against Infection by Both Mucoid and Nonmucoid Strains

Published:2004-10-19 Issue:9 Volume:173 Page:5671-5678
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Pier Gerald B.,Boyer Debra,Preston Michael,Coleman Fadie T.,Llosa Nicolas,Mueschenborn-Koglin Simone,Theilacker Christian,Goldenberg Hannah,Uchin Jeffrey,Priebe Gregory P.,Grout Martha,Posner Marshall,Cavacini Lisa

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference55 articles.

1. Phenotypic differences among clinically isolated mucoid Pseudomonas aeruginosa strains

2. Cystic Fibrosis Foundation. 2003. Patient registry 2002: annual report, Bethesda, MD.

3. Longitudinal Assessment ofPseudomonas aeruginosain Young Children with Cystic Fibrosis

4. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition

5. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis.

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Semisynthetic Oligomannuronic Acid-Based Glycoconjugate Vaccine against Pseudomonas aeruginosa;ACS Central Science;2024-07-10

2. Poly-β-(1→6)-N-acetyl-D-glucosamine mediates surface attachment, biofilm formation, and biocide resistance in Cutibacterium acnes;Frontiers in Microbiology;2024-05-01

3. How Three Self-Secreted Biofilm Exopolysaccharides of Pseudomonas aeruginosa, Psl, Pel, and Alginate, Can Each Be Exploited for Antibiotic Adjuvant Effects in Cystic Fibrosis Lung Infection;International Journal of Molecular Sciences;2023-05-13

4. Polysaccharides’ Structures and Functions in Biofilm Architecture of Antimicrobial-Resistant (AMR) Pathogens;International Journal of Molecular Sciences;2023-02-17

5. A high-throughput sequencing approach identifies immunotherapeutic targets for bacterial meningitis in neonates;eBioMedicine;2023-02